Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET
Intelligent Bio Solutions (INBS) has announced a virtual fireside chat scheduled for December 11, 2024, at 4:30 p.m. ET. The event will feature President & CEO Harry Simeonidis and CFO Spiro Sakiris, who will discuss the company's recent clinical study results and their path to FDA 510(k) submission.
The virtual presentation will include a Q&A session for investors, and a recording will be made available on the company's Investor Relations website following the event. Interested participants can register through the provided Zoom webinar link.
Intelligent Bio Solutions (INBS) ha annunciato un incontro virtuale a fuoco programmato per l'11 dicembre 2024, alle 16:30 ET. L'evento vedrà la presenza del Presidente e CEO Harry Simeonidis e del CFO Spiro Sakiris, i quali discuteranno i recenti risultati degli studi clinici dell'azienda e il loro percorso verso la sottomissione FDA 510(k).
La presentazione virtuale includerà una sessione di domande e risposte per gli investitori e una registrazione sarà disponibile sul sito web delle Relazioni con gli Investitori dell'azienda dopo l'evento. I partecipanti interessati possono registrarsi tramite il link fornito per il webinar Zoom.
Intelligent Bio Solutions (INBS) ha anunciado un chat virtual programado para el 11 de diciembre de 2024, a las 4:30 p.m. ET. El evento contará con el Presidente y CEO Harry Simeonidis y el CFO Spiro Sakiris, quienes discutirán los resultados recientes del estudio clínico de la empresa y su camino hacia la presentación del FDA 510(k).
La presentación virtual incluirá una sesión de preguntas y respuestas para inversionistas, y una grabación estará disponible en el sitio web de Relaciones con Inversionistas de la empresa tras el evento. Los participantes interesados pueden registrarse a través del enlace proporcionado para el webinar de Zoom.
인텔리전트 바이오 솔루션즈 (INBS)는 2024년 12월 11일 오후 4시 30분 ET에 예정된 가상 화상 대담을 발표했습니다. 본 이벤트에서는 CEO 해리 시메오니다스와 CFO 스피로 사키리스를 초대하여 최근 임상 연구 결과와 FDA 510(k) 제출 경로를 논의할 예정입니다.
가상 발표에서는 투자자들을 위한 Q&A 세션이 포함되며, 이벤트 후에는 회사의 투자자 관계 웹사이트에서 녹화된 내용이 제공될 예정입니다. 관심 있는 참가자는 제공된 줌 웨비나 링크를 통해 등록할 수 있습니다.
Intelligent Bio Solutions (INBS) a annoncé une discussion virtuelle prévue pour le 11 décembre 2024 à 16h30 ET. L'événement mettra en vedette le Président et CEO Harry Simeonidis ainsi que le CFO Spiro Sakiris, qui discuteront des résultats récents des études cliniques de l'entreprise et de leur chemin vers la soumission FDA 510(k).
La présentation virtuelle comprendra une session de questions-réponses pour les investisseurs, et un enregistrement sera disponible sur le site Web des Relations investisseurs de l'entreprise après l'événement. Les participants intéressés peuvent s'inscrire via le lien fourni pour le webinaire Zoom.
Intelligent Bio Solutions (INBS) hat einen virtuellen Kaminabend für den 11. Dezember 2024 um 16:30 Uhr ET angekündigt. Bei der Veranstaltung werden Präsident und CEO Harry Simeonidis sowie CFO Spiro Sakiris teilnehmen, die die aktuellen Ergebnisse der klinischen Studien des Unternehmens und ihren Weg zur FDA 510(k) Einreichung erörtern werden.
Die virtuelle Präsentation beinhaltet eine Fragerunde für Investoren, und eine Aufzeichnung wird nach der Veranstaltung auf der Investor Relations-Website des Unternehmens verfügbar sein. Interessierte Teilnehmer können sich über den bereitgestellten Link zum Zoom-Webinar anmelden.
- None.
- None.
NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it will host a virtual fireside chat with Harry Simeonidis, President & CEO and Spiro Sakiris, CFO at 4:30 p.m. ET on December 11, 2024.
During the event, management will discuss the Company's recent clinical study results, path to FDA 510(k) submission, and offer investors an opportunity to ask questions.
Virtual Fireside Chat Details:
Dates: December 11, 2024
Presentation Time: 4:30 p.m. ET
Registration Link: https://us02web.zoom.us/webinar/register/WN_FtL7WYRoRa2qYU6x-WybGQ#/registration
A Q&A portion will occur at the end of the call and a link to the recording of the presentation will be available on INBS’ Investor Relations website after the event.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When is Intelligent Bio Solutions (INBS) hosting their virtual fireside chat?
What topics will be covered in INBS's December 2024 fireside chat?
Who will be presenting at the INBS December 2024 fireside chat?
How can investors access INBS's December 2024 fireside chat?
